BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Emmes (CRO) Acquires Clinical Edge

- Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical in...

September 30, 2022 | News

WuXi Biologics Topped Off the Steel on its Commercial Biomanufacturing Facility

WuXi Biologics ("WuXi Bio") (2269.HK), a global Contract Research, Development and Manufacturing Organization (CRDMO), held a topping-off ceremony, i...

September 29, 2022 | News

Rapid growth puts Australian CRO Accelagen on the map for clinical research globally

Accelagen, one of Australia's leading Contract Research Organisations, has taken new 472sqM office space in Hawthorn East following two year...

September 20, 2022 | News

APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report

Download report here https://novotech-cro.com/whitepapers/evolution-clinical-trials-asia-pacific-region-compared-us-and-eu5In addition, the GlobalData...

September 05, 2022 | News

WuXi Biologics Announces GMP Release of Its First North American Biomanufacturing Facility

The site's clinical manufacturing operations have an initial capacity of 4,000L and will grow to 6,000L, utilizing only single-use technology, adding to th...

September 01, 2022 | News

Nuance Pharma Announces Clearance of IND Application for Ensifentrine Pivotal Clinical Trials for COPD in China

Ensifentrine is a first-in-class, dual inhibitor of the enzymes phosphodiesterase 3 and 4 ("PDE3" and "PDE4") combining bronchodilator and anti-inflam...

August 21, 2022 | News

Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15

-Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced the initiation of a Phase 3 clinical study, Vacc...

August 09, 2022 | News

LG Chem Enters Final Stage of Clinical Development for New Gout Drug

In global Phase 3 clinical trial, Tigulixostat will be evaluated in 350 adult gout patients with hyperuricemia for safety and efficacy at Month 6 of treatm...

August 04, 2022 | News

Thermo Fisher Scientific Showcases New Clinical and Research Lab Solutions at AACC 2022

Thermo Fisher Scientific Inc., the world leader in serving science, is showcasing innovative diagnostic technologies, assays and a complement of solutions ...

July 26, 2022 | News

Ozgene and Gen-H partner on Ozgene’s new OzBIG targeted humanization capability

Ozgene and Gen-H are pleased to announce our working partnership supporting Ozgene’s new OzBIG capability. Ozgene Pty Ltd is a privately held CRO bas...

July 25, 2022 | News

Pulnovo Medical Concludes Successfully First Pre-Sub Meeting with FDA for PADN Global Clinical Trial

Dr. Shaoliang Chen, Chair of Pulnovo Medical's Scientific Advisory Board and pioneer of the PADN technology, attended the meeting and presented the co...

July 18, 2022 | News

Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea

SK bioscience and GSK recently announced the successful authorization:SK bioscience announced that 'SKYCovione(TM),' South Korea's first COVID-19 vaccine c...

July 14, 2022 | News

WuXi XDC and AbTis Sign Memorandum of Understanding for Development and Manufacturing of Antibody Drug Conjugates

Under the partnership, AbTis will have access to WuXi XDC's integrated services for linker and payload manufacturing, ADC conjugation process developm...

July 08, 2022 | News

Clinical Trial Approval For mRNA Covid-19 Vaccine For Omicron Variant In The Philippines

R520A is an mRNA COVID-19 vaccine specifically targeting the Omicron variant developed by Wuhan Recogen Biotechnology Co., Ltd., a subsidiary of the Compan...

June 28, 2022 | News

Stay Connected